UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Eteplirsen in the treatment of Duchenne muscular dystrophy

Drug design, development and therapy, 2017-01, Vol.11, p.533-545

2017

Volltextzugriff (PDF)

Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy

Proceedings of the National Academy of Sciences - PNAS, 2022-03, Vol.119 (9), p.1

2022

Volltextzugriff (PDF)

Exonic mutations and exon skipping: Lessons learned from DFNA5

Human mutation, 2018-03, Vol.39 (3), p.433-440

2018

Volltextzugriff (PDF)

Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates

Molecular therapy, 2019-01, Vol.27 (1), p.76-86

2019

Volltextzugriff (PDF)

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges

Journal of personalized medicine, 2018-12, Vol.8 (4), p.41

2018

Volltextzugriff (PDF)

Alternative Splicing Increases Sirtuin Gene Family Diversity and Modulates Their Subcellular Localization and Function

International journal of molecular sciences, 2021-01, Vol.22 (2), p.473

2021

Volltextzugriff (PDF)

Antisense Oligonucleotide Modified with Disulfide Units Induces Efficient Exon Skipping in mdx Myotubes through Enhanced Membrane Permeability and Nucleus Internalization

Chembiochem : a European journal of chemical biology, 2021-12, Vol.22 (24), p.3437-3442

2021

Volltextzugriff (PDF)

Zebrafish as a Model to Evaluate a CRISPR/Cas9-Based Exon Excision Approach as a Future Treatment Option for EYS-Associated Retinitis Pigmentosa

International journal of molecular sciences, 2021-09, Vol.22 (17), p.9154

2021

Volltextzugriff (PDF)

Trimerization profile of type IV collagen COL4A5 exon deletion in X-linked Alport syndrome

Clinical and experimental nephrology, 2024-09, Vol.28 (9), p.874-881

2024

Volltextzugriff (PDF)

Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues

Nucleic acid therapeutics, 2017-10, Vol.27 (5), p.251-259

2017

Volltextzugriff (PDF)

Synthesis and Exon-Skipping Properties of a 3'-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach

Molecules (Basel, Switzerland), 2021-12, Vol.26 (24), p.7662

2021

Volltextzugriff (PDF)

Trans‐generational epigenetic regulation associated with the amelioration of Duchenne Muscular Dystrophy

EMBO molecular medicine, 2020-08, Vol.12 (8), p.e12063-n/a

2020

Volltextzugriff (PDF)

Oxytocin accelerates tight junction formation and impairs cellular migration in 3D spheroids: evidence from Gapmer-induced exon skipping

Frontiers in cellular neuroscience, 2022-10, Vol.16, p.1000538-1000538

2022

Volltextzugriff (PDF)

Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy

Journal of personalized medicine, 2018-11, Vol.8 (4), p.38

2018

Volltextzugriff (PDF)

Gene modification strategies using AO‐mediated exon skipping and CRISPR/Cas9 as potential therapies for Duchenne muscular dystrophy patients

Engineering biology, 2020-12, Vol.4 (3), p.37-42

2020

Volltextzugriff (PDF)

Natural Disease Course in Usher Syndrome Patients Harboring USH2A Variant p.Cys870 in Exon 13, Amenable to Exon Skipping Therapy

Genes, 2023-03, Vol.14 (3), p.652

2023

Volltextzugriff (PDF)

Pathological Issues in Dystrophinopathy in the Age of Genetic Therapies

Annual review of pathology, 2019-01, Vol.14 (1), p.105-126

2019

Volltextzugriff (PDF)

Analysis and Prediction of Exon Skipping Events from RNA-Seq with Sequence Information Using Rotation Forest

International journal of molecular sciences, 2017-12, Vol.18 (12), p.2691

2017

Volltextzugriff (PDF)

Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function

2021

Volltextzugriff (PDF)

Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models

Cells (Basel, Switzerland), 2023-03, Vol.12 (6), p.908

2023

Volltextzugriff (PDF)

AON-Mediated Exon Skipping to Bypass Protein Truncation in Retinal Dystrophies Due to the Recurrent CEP290 c.4723A > T Mutation. Fact or Fiction?

Genes, 2019-05, Vol.10 (5), p.368

2019

Volltextzugriff (PDF)

Corrigendum: Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping

RNA (Cambridge), 2018-12, Vol.24 (12), p.1886-1886

2018

Volltextzugriff (PDF)

Skipping Multiple Exons to Treat DMD-Promises and Challenges

Biomedicines, 2018-01, Vol.6 (1), p.1

2018

Volltextzugriff (PDF)

Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy

Journal of personalized medicine, 2017-10, Vol.7 (4), p.13

2017

Volltextzugriff (PDF)

Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy

Journal of personalized medicine, 2019-03, Vol.9 (1), p.16

Nakamura, Akinori

2019

Volltextzugriff (PDF)

1 – 25 von 1.371

Suche als RSS-Feed

Aktive Filter

ThemaExon Skipping

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.251)
Mit Volltextzugriff
(1.179)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Eteplirsen in the treatment of Duchenne muscular dystrophy

Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy

Exonic mutations and exon skipping: Lessons learned from DFNA5

Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges

Alternative Splicing Increases Sirtuin Gene Family Diversity and Modulates Their Subcellular Localization and Function

Antisense Oligonucleotide Modified with Disulfide Units Induces Efficient Exon Skipping in mdx Myotubes through Enhanced Membrane Permeability and Nucleus Internalization

Zebrafish as a Model to Evaluate a CRISPR/Cas9-Based Exon Excision Approach as a Future Treatment Option for EYS-Associated Retinitis Pigmentosa

Trimerization profile of type IV collagen COL4A5 exon deletion in X-linked Alport syndrome

Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues

Synthesis and Exon-Skipping Properties of a 3'-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach

Trans‐generational epigenetic regulation associated with the amelioration of Duchenne Muscular Dystrophy

Oxytocin accelerates tight junction formation and impairs cellular migration in 3D spheroids: evidence from Gapmer-induced exon skipping

Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy

Gene modification strategies using AO‐mediated exon skipping and CRISPR/Cas9 as potential therapies for Duchenne muscular dystrophy patients

Natural Disease Course in Usher Syndrome Patients Harboring USH2A Variant p.Cys870 in Exon 13, Amenable to Exon Skipping Therapy

Pathological Issues in Dystrophinopathy in the Age of Genetic Therapies

Analysis and Prediction of Exon Skipping Events from RNA-Seq with Sequence Information Using Rotation Forest

Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function

Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models

AON-Mediated Exon Skipping to Bypass Protein Truncation in Retinal Dystrophies Due to the Recurrent CEP290 c.4723A > T Mutation. Fact or Fiction?

Corrigendum: Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping

Skipping Multiple Exons to Treat DMD-Promises and Challenges

Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy

Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy

Aktive Filter

Suchergebnisse filtern